AUSTIN, TX / ACCESS Newswire / September 11, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of…
One Billion People Living With Mental Health Conditions ATLANTA, GA / ACCESS Newswire / September 11, 2025 / The World…
One Billion People Living With Mental Health Conditions ATLANTA, GA / ACCESS Newswire / September 11, 2025 / The World…
The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development,…
This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, 2025…
SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a…
SIOUX FALLS, SD / ACCESS Newswire / September 11, 2025 / Avel eCare today announced that Dr. Kelly Rhone, Chief…
Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical…
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1Filing based on four Phase 3…
MORRISTOWN, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today…